Cheeky Bonsai Cramp Killer Pain Relief Patches

Description

The product is identified by the SPL code 34089-3. No specific description details are provided in the text.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with menstrual cramps, simple backache, leg cramps, strains, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 12 years and older, the recommended dosage involves the application of a transdermal patch. Prior to application, the healthcare professional should instruct the patient to remove the backing from the patch. The patch should then be applied directly to the affected area of the skin.

The patch is designed to be worn for a maximum duration of 12 hours. It is essential to ensure that the patch adheres properly to the skin to facilitate optimal delivery of the medication.

Contraindications

There are no specific contraindications listed for this product. However, it is imperative to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed.

Warnings and Precautions

For external use only, this product must be utilized strictly as directed. Healthcare professionals should advise patients to apply no more than one patch at a time and to refrain from using it concurrently with other topical analgesics. It is imperative that the product is not applied to wounds or damaged skin to prevent adverse effects.

While using this product, patients should be cautioned to avoid contact with the eyes and other mucous membranes. Additionally, it is important not to bandage the area tightly, as this may lead to increased absorption and potential toxicity.

Patients should be instructed to discontinue use and consult a healthcare provider if the condition worsens or if symptoms persist for more than 7 days. If symptoms resolve and then recur within a few days, medical advice should also be sought.

For individuals who are pregnant or breastfeeding, it is essential to consult a healthcare professional prior to use. Furthermore, this product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought or contact with a Poison Control Center should be made without delay.

Side Effects

Patients using this product should be aware of several important warnings and precautions. The product is intended for external use only and should be used strictly as directed. It is contraindicated to apply more than one patch at a time, to use it concurrently with other topical analgesics, or to apply it on wounds or damaged skin.

While using this product, patients should avoid contact with the eyes and other mucous membranes, and should not bandage the area tightly. If a patient's condition worsens, or if symptoms persist for more than 7 days or resolve and then recur within a few days, they should discontinue use and consult a healthcare professional. Additionally, it is advised that patients who are pregnant or breastfeeding seek guidance from a health professional prior to use.

Drug Interactions

Concurrent use of this medication with other topical analgesics is contraindicated. The combination may lead to an increased risk of adverse effects without providing additional therapeutic benefit. Therefore, it is advised to avoid using this medication simultaneously with any other topical analgesic agents.

No specific interactions with laboratory tests have been identified. Monitoring for laboratory test results is not required in relation to this medication.

Packaging & NDC

Below are the non-prescription pack sizes of Cheeky Bonsai Cramp Killer Pain Relief Patches (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 12 years and older may receive the same dosage as adults. There is limited data on the safety and efficacy of this medication in children under 12 years of age. Therefore, caution is advised when considering treatment in this population. Further studies are needed to establish appropriate dosing and safety profiles for younger pediatric patients.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits, as well as any available data regarding fetal outcomes and lactation. Healthcare providers should consider individual circumstances and the specific health needs of the patient when making recommendations.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating mothers.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the text. Therefore, healthcare professionals should exercise caution and consider individual patient factors when prescribing to this population. Regular assessment of renal function may be warranted to ensure safe and effective use of the medication in patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. It is imperative that healthcare providers remain vigilant and prepared to address any complications that may arise from an overdosage scenario.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question.

Postmarketing Experience

No postmarketing experience details are available for SPL code 90375-7.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. It is important to emphasize that if the medication is swallowed, patients should seek medical help or contact a Poison Control Center immediately. This guidance is crucial for ensuring the safety and well-being of patients and their families.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature, ensuring that the temperature does not exceed 80°F (27ºC). Proper storage conditions are crucial to maintain the integrity and efficacy of the product.

Additional Clinical Information

The product is administered topically, with a recommended wear time of up to 12 hours. Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. It is also important to instruct patients to keep the product out of reach of children and to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed.

Drug Information (PDF)

This file contains official product information for Cheeky Bonsai Cramp Killer Pain Relief Patches, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)